Email updates

Keep up to date with the latest news and content from BMC Neurology and BioMed Central.

Open Access Highly Accessed Research article

Comparison of once-daily versus twice-daily combination of Ropinirole prolonged release in Parkinson’s disease

Ji Young Yun1, Han-Joon Kim23, Jee-Young Lee4, Young Eun Kim5, Ji Seon Kim6, Jong-Min Kim5 and Beom S Jeon23*

Author Affiliations

1 Department of Neurology, Ewha Womans University Mokdong Hospital, Seoul, Korea

2 Department of Neurology, College of Medicine, Seoul National University, Seoul, Korea

3 Movement Disorder Center, Seoul National University Hospital, Seoul, Korea

4 Department of Neurology, Seoul National University-Seoul Metropolitan Government Boramae Medical Center, Seoul, Korea

5 Department of Neurology, Seoul National University Bundang Hospital, Sungnam, Korea

6 Department of Neurology, Chungbuk National University Hospital, Cheongju, Korea

For all author emails, please log on.

BMC Neurology 2013, 13:113  doi:10.1186/1471-2377-13-113

Published: 2 September 2013

Additional files

Additional file 1:

Dose switches from conventional dopamine agonists to ropinirole PR.

Format: DOCX Size: 16KB Download file

Open Data

Additional file 2:

Adverse events.

Format: DOCX Size: 14KB Download file

Open Data